The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Hematopoietic Growth Factors Secreted by Seven Human Pleural Mesothelioma Cell Lines: Interleukin-6 Production as a Common Feature
Abstract
Seven mesothelioma cell lines, established from patients with pleural mesothelioma, exhibited substantial heterogeneity regarding in vitro morphology and growth characteristics. Media conditioned by these cell lines and by MeT5A normal mesothelial cells were examined for (i) colony formation on human bone-marrow cells, (ii) hematopoietic growth-factor content and (iii) mitogenic activity on mesothelioma cells. Colony-stimulating activity was produced only by the ZL34 cell line. Analysis of conditioned media by ELISA revealed that all mesothelioma cell lines constitutively produced IL-6, while the MeT5A normal mesothelial cells did not; in addition, GM-CSF and G-CSF were detected in the supernatant of the ZL34 cell line. Using a 3H-thymidine incorporation assay, we showed that all mesothelioma cell lines produced mitogenic activity in the culture supernatant, in contrast to the MeT5A normal mesothelial cells. The mitogenic effect of the hematopoietic growth factors detected in mesothelioma culture supernatants was tested on mesothelioma cells and on MeT5A normal mesothelial cells: IL-6, GM-CSF and G-CSF did not stimulate any DNA synthesis. Our results suggest that these hematopoietic growth factors do not act as autocrine growth factors. A common feature of this panel of mesothelioma cell lines is the production of IL-6; although the biological significance of the aberrant production of cytokines by mesotheliomas remains unclear, IL-6 might be involved in paraneoplastic syndromes such as thrombocytosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mesothelioma cells produce IL-6 [45,46]”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [46]
In the citing paper
“Mesothelioma cells produce IL-6 [45,46], and an elevation of the circulating level of IL-6 has been already described in mesothelioma patients, with this increase being associated with a negative clinical condition. High levels of IL-6 have been also revealed in patients’ pleural fluids [47].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [46]
Citations
Cites
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F., & Akiyama, Y. (1989) · Blood · doi:10.1182/blood.v74.4.1241.1241 · Cited by 432
Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas
Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., & Kishimoto, T. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80805-1 · Cited by 411
Diffuse Malignant Mesothelioma: Prospective Evaluation of 69 Patients
CHAHINIAN, A. P., PAJAK, T. F., HOLLAND, J. F., NORTON, L., AMBINDER, R. M., & MANDEL, E. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-6-746 · Cited by 354
The Pathogenesis of Asbestos-Associated Diseases
Craighead, J. E., & Mossman, B. T. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206173062403 · Cited by 333
Berdel, W., Danhauser-Riedl, S., Steinhauser, G., & Winton, E. (1989) · Blood · doi:10.1182/blood.v73.1.80.80 · Cited by 289
In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets
Asano, S., Okano, A., Ozawa, K., Nakahata, T., Ishibashi, T., Koike, K., Kimura, H., Tanioka, Y., Shibuya, A., & Hirano, T. (1990) · Blood · doi:10.1182/blood.v75.8.1602.1602 · Cited by 279
(1987) · Lung Cancer · doi:10.1016/s0169-5002(87)80408-7 · Cited by 263
Frei, K., Leist, T. P., Meager, A., Gallo, P., Leppert, D., Zinkernagel, R. M., & Fontana, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.1.449 · Cited by 245
Dedhar, S., Gaboury, L., Galloway, P., & Eaves, C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9253 · Cited by 229
Research works printed but not linked: 1
- Lee J. D., 1991, Proceedings of the 82th annual meeting AACR. Houston, 228
Cited by
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Malignant Pleural Mesothelioma
Tsao, A. S., Wistuba, I., Roth, J. A., & Kindler, H. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8523 · Cited by 481
Spatio‐temporally precise activation of engineered receptor tyrosine kinases by light
Grusch, M., Schelch, K., Riedler, R., Reichhart, E., Differ, C., Berger, W., Inglés‐Prieto, Á., & Janovjak, H. (2014) · The EMBO Journal · doi:10.15252/embj.201387695 · Cited by 245
“We first screened cells from different tumour entities for effects of FGF2, a prominent FGFR ligand, and we identified two cell lines derived from malignant pleural mesothelioma to be FGF2responsive (M38K and SPC212; Schmitter et al, 1992; Kahlos et al, 1998).”
BackgroundKroegel, C., & Antony, V. B. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10102411 · Cited by 232
“In addition to IL-8, a recent study showed that C5a may also contribute significantly to pleural accumulation of neutrophils following instillation of the streptococcal preparation OK-432 [ 3 ].”
BackgroundInfluentialImpact of pretreatment thrombocytosis on survival in primary breast cancer
Salat, A., Gnant, M., Kwasny, W., Mlineritsch, B., Menzel, R.-C., Schmid, M., Smola, M. G., Stierer, M., Tausch, C., Galid, A., et al. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613413 · Cited by 174
“One possible candidate is interleukin 6, since blood levels are reported to be high in malignant disease (36, 49, 50) and interleukin 6 is produced by various non-hematological cancer entities (51-55).”
Background
Metadata
- Authors
- Schmitter, D., Lauber, B., Fagg, B., & Stahel, R. A.
- Affiliations
- University Hospital Zurich (CH)
- Sandoz Group AG (Switzerland) (CH)
- Corresponding author
- Stahel, Rolf A.
- ORCID
- Stahel, Rolf A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1992-05-08
- Volume
- 51
- Issue
- 2
- Pages
- 296-301
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2008766290
- Cited by
- 133
- References
- 27
- Citations by year
- 2024: 3 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 5 · 2018: 8 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 2 · 2012: 8
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- China Aerospace Science and Technology Corporation
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Keywords
- pleural mesothelioma, hematopoietic growth factors, interleukin-6, GM-CSF, granulocyte colony-stimulating factor, conditioned medium, colony-stimulating activity, mitogenic activity, autocrine growth factor, paraneoplastic syndrome, thrombocytosis, mesothelial cells, cancer cell lines
- MeSH terms
- Humans, Mesothelioma, Pleural Neoplasms, Tumor Cells, Cultured, Tumor Stem Cell Assay, Interleukin-6, Granulocyte-Macrophage Colony-Stimulating Factor, Granulocyte Colony-Stimulating Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hematopoietic Growth Factors Secreted by Seven Human Pleural Mesothelioma Cell Lines: Interleukin-6 Production as a Common Feature. https://app.cochat.ai/papers/10.1002/ijc.2910510220
- The paper
- Schmitter, D., Lauber, B., Fagg, B., & Stahel, R. A. (1992). Hematopoietic Growth Factors Secreted by Seven Human Pleural Mesothelioma Cell Lines: Interleukin-6 Production as a Common Feature. International Journal of Cancer. https://doi.org/10.1002/ijc.2910510220
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.